About
Basic Data Updated:
1 day ago"Discover the world of pharmaceutical excellence with SYNCOM FORMULATIONS (INDIA) LIMITED. As a leading manufacturer of pharmaceutical formulations, SFIL offers a diverse range of products in tablets, capsules, liquids, injections, syrups, ointments, inhalers, and herbals. With a global presence in over 15 countries and a portfolio of over 400 registered products, SFIL is committed to providing high-quality and affordable healthcare solutions. Founded in 1988, the company's state-of-the-art manufacturing unit is located in Pithampur, ensuring the highest standards of production. Trust in SFIL for all your pharmaceutical needs."
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L24239MH1988PLC047759 |
| Company No. | 047759 |
| Stock Symbol | BSE : 524470 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 21 Jun 1988 |
| Date of AGM | 26 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Mumbai |
Products or Services related to Syncom Formulations (India) Limited
Plastic Film
Diclofenac
Oral Suspension
Multivitamin Syrup & Drops
Financials of Syncom Formulations (India) Limited
Syncom Formulations (India) Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.05% decrease. The company also saw a substantial fall in profitability, with a 32.16% decrease in profit. The company's net worth Soared by an impressive increase of 18.47%.
Corporate Structure
Unlock access to Syncom Formulations (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Syncom Formulations (India) Limited
Unlock and access historical data on people associated with Syncom Formulations (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
VB
Vijay Bankda
Managing DirectorAppointment Date: 01-Dec-1999
Status: Current
AB
Ankit Bankda CFOAppointment Date: 01-Apr-2014
Status: Current
VA
Vaishali Agrawal Company SecretaryAppointment Date: 03-May-2023
Status: Current
Board Members(5)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Dec 2020 | ₹100.00 Cr | Open |
Dena Bank Creation Date: 23 May 2002 | ₹12.77 Cr | Satisfied |
Dena Bank Creation Date: 23 May 2002 | ₹12.77 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syncom Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syncom Formulations (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sante Biotech Private Limited
Active
1 year 9 months Vijay Bankda and Kedarmal Bankda are mutual person
Synmex Pharma Private Limited
Active 1 year 9 months Vijay Bankda and Kedarmal Bankda are mutual person
Vincit Biotech International Private Limited
Active 1 year 9 months Vijay Bankda and Kedarmal Bankda are mutual person
Recent activity within the organization
Annual General Meeting
Syncom Formulations (India) Limited last Annual general meeting of members was held on 26 Sep 2023 as per latest MCA records.
26 Sep 2023Director Appointment
Ankit Jain was appointed as a Director was appointed as a Director on 14 Aug 2023 & has been associated with this company since 9 months 2 days .
14 Aug 2023Balance Sheet
Syncom Formulations (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Ruchi Jindal was appointed as a Director was appointed as a Director on 28 Jun 2022 & has been associated with this company since 1 year 10 months .
28 Jun 2022Charges
A charge with Hdfc Bank Limited of Rs. 100.00 cr registered on 28 Dec 2020 with Charge ID 100407475 was modified on 06 Oct 2021.
06 Oct 2021
Recent News, Updates & Announcement
Syncom Formulations India Outcome of board meeting.Syncom Formulations India has informed about Outcome of Board Meeting held on February 13 2017.
Moneycontrol 13 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Syncom Formulations (India) Limited?
